Brief: Aap Implantate: Progress Regarding Preparations For Human Clinical Study in Antibacterial Silver Coating Technology
March 29 (Reuters) - AAP IMPLANTATE AG AAQG.DE :
* DGAP-NEWS: ANTIBACTERIAL SILVER COATING TECHNOLOGY: GOOD
PROGRESS REGARDING PREPARATIONS FOR HUMAN CLINICAL STUDY - START
AIMED FOR 2018
* AAP IMPLANTATE - MADE SUBSTANTIAL PROGRESS IN PREPARING
HUMAN
CLINICAL STUDY FOR AIMED CE AND FDA APPROVAL OF ITS
ANTIBACTERIAL SILVER COATING TECHNOLOGY IN RECENT MONTHS
* AIMS TO START HUMAN CLINICAL STUDY IN COURSE OF CURRENT
FINANCIAL YEAR
Source text for Eikon: ID:nEQ41PqDNa
Further company coverage: AAQG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on aap Implantate AG
See all newsBrief: Aap Confirms Rubino Di Girolamo As CEO Through The End Of 2028 COO Agnieszka Mierzejewska Will Leave The Company At The End Of The Year
Brief: aap Implantate Says Postponement Of Publication Of Annual Financial Statements
Brief: Aap Implantate AG Says Increases Its EBITDA In 9M From - 1.6 Mln Euros To 0 Euros
Brief: aap Implantate Says Resumes Step-By-Step Restart Of It Systems
Brief: Aap Implantate Says Possible Cyber Attack On Co